TTD | Drug: D0U3SY

Drug General Information
Drug ID	D0U3SY
Drug Name	Alectinib
Drug Type	Small molecular drug
Indication	Lung Cancer [ICD10:C33-C34]	Approved	[1572608]
Indication	Discovery agent	Investigative	[1572605]
Formula	C30H34N4O2
PubChem Compound ID	49806720
Drug Resistance Mutation (DRM)
DRM	DRM Info
References
Ref 1572605	The ChEMBL database in 2017.
Ref 1572608	Alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.

Drug Information